Yongmaotai: the net profit in the first half of the year was 122 million yuan, a year-on-year increase of 76%

We-Linking Raised Over CNY 10 Mn in Angel Round

Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round

Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries

Several new funds have actively picked up chips to speed up the pace of position building

The 14th five year development plan of Shenzhen national high tech Zone aims to reach 200 listed enterprises in the zone by 2025

The third top stream of 100 billion was born! Ge Lan was "more down, more buy", and the scale soared by 10 billion

There are more than 3000 reception institutions a year, and Mindray medical has become the most concerned company in 2021

During the year, the issuance of A-share convertible bonds was "cold" and the scale of bond issuance on the gem rose against the trend

Anxin Securities: the performance of Mindray medical is in line with expectations, and the six-month target price is 440.8 yuan

Aeroengine power: the subsidiary intends to acquire some assets of Liming technology

Northbound capital increased its position by 26 shares for 7 consecutive weeks

Zhongyuan expressway: the net profit in the first half of the year was 642 million yuan, turning losses into profits year-on-year

Pharmaceutical and medical stocks fell sharply in early trading, and Hengrui pharmaceutical fell more than 9%

In the second quarter, the public fund's heavy position stocks are released, and Guizhou Maotai is still the largest heavy position stocks